Strategic partnerships Active Motif distribution deal indicates appetite for collaboration with niche genomics players; explore similar co-marketing and distribution partnerships to expand Hi-C kit reach and accelerate adoption in oncology research.

Clinical adoption Multiple partnerships with cancer centers (Fox Chase, potential AMPath, and others) and awards recognition suggest growing credibility; target additional cancer institutes and pathology labs to widen access to Aventa Lymphoma and 3D genome analysis solutions.

Evidence-driven Presented data at AMP Europe and recognition in Fast Company World Changing Ideas bolster credibility; leverage case studies and user validation to propel outbound campaigns and benchmark competitors.

Growth indicators Revenue is mid tens of millions with substantial funding; pursue enterprise deals with mid to large biotech labs and contract research organizations seeking integrated sequencing and 3D structure insights.

Expansion signals Recent awards, partnerships, and demonstrations at international events point to geographic and channel expansion; prioritize international systems biology and translational research buyers, plus distributors in Europe and beyond.